ClinicalTrials.govpublic full text
Capecitabine + Bevacizumab in Patients With Recurrent Glioblastoma
glioblastoma, myeloid derived suppressor cells, brain tumor, mdsc, gbm, recurrent, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895675
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.